The Drug Regulatory Authority of Pakistan (DRAP) has announced a rigorous, phased ban on the manufacture, import, and sale of conventional disposable syringes, shifting entirely toward safety-engineered reuse-prevention (RUP) models. Following a directive from Prime Minister Shehbaz Sharif to eliminate substandard medical equipment, DRAP’s board finalized December 31, 2026, as the strict cut-off deadline. Consequently, beginning January 1, 2027, the retail and market sale of conventional 1cc (non-insulin) and 10cc disposable syringes will be legally prohibited across the country.
The policy shift comes in response to alarming epidemiological data linking unsafe injection practices to the spread of blood-borne diseases. Health taskforce findings revealed that the illicit reuse of standard plastic syringes is a major driver behind localized HIV and hepatitis outbreaks, including thousands of new cases recorded across Punjab and Sindh over recent years. To completely mitigate these risks, the market will transition exclusively to RUP syringes equipped with auto-lock, auto-destructible, or retractable technologies that break or lock permanently after a single clinical use.
To prevent supply chain disruptions while maintaining medical safeguards, DRAP has introduced localized exemptions for specialized hospital settings. While conventional 10cc syringes are banned from public retail markets, their supply will be restricted strictly to secondary and tertiary healthcare facilities for intricate clinical procedures. Manufacturers will be legally required to indelibly print the procuring hospital’s name on the primary packaging, and institutions must establish internal digital inventory tracking to prevent these conventional units from leaking back into the open commercial market.
